Hepatic encephalopathy: Diagnosis and management

被引:62
作者
Amodio, Piero [1 ]
机构
[1] Univ Padua, Dept Med DIMED & CIRMANMEC, Padua, Italy
关键词
cirrhosis; delirium; hepatic encephalopathy; portal-systemic shunt; PORTAL-SYSTEMIC ENCEPHALOPATHY; CHRONIC LIVER-FAILURE; ORNITHINE L-ASPARTATE; RANDOMIZED CONTROLLED-TRIAL; WHOLE GUT IRRIGATION; CIRRHOTIC-PATIENTS; CEREBRAL EDEMA; DOUBLE-BLIND; NITROGEN-METABOLISM; MANNITOL SOLUTION;
D O I
10.1111/liv.13752
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Hepatic encephalopathy (HE) is a peculiar kind of brain dysfunction caused by liver insufficiency and/or portal-systemic shunting. It is related to gut-derived substances. It is a relevant cause of morbidity and hospitalisation for patients with cirrhosis. The prognosis of HE is important in terms of survival and re-hospitalisation. It is related to impaired quality of life, falls and poor driving; presents a relevant burden for caregivers and health services; and may negatively impact on patient's job and income. Proper diagnosis and classification are expected to improve HE management. Once diagnosed, the management and therapeutic options for HE are generally clear. The improvement of knowledge in recent years has also clarified which are the further aims of research in this field of medicine. Prophylaxis of overt HE should always be performed, and this is generally secondary prophylaxis. Primary prophylaxis should be done immediately after upper gastrointestinal bleeding. Great advances in the detection and treatment of mild forms of HE are expected to lead to further improvement in patient management.
引用
收藏
页码:966 / 975
页数:10
相关论文
共 84 条
[1]
Aires FT, 1992, REV ASSOC MED BRAS, V2016, P243
[2]
Attention dysfunction in cirrhotic patients: An inquiry on the role of executive control, attention orienting and focusing [J].
Amodio P. ;
Schiff S. ;
Del Piccolo F. ;
Mapelli D. ;
Gatta A. ;
Umiltà C. .
Metabolic Brain Disease, 2005, 20 (2) :115-127
[3]
Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients [J].
Amodio, P ;
Del Piccolo, F ;
Pettenò, E ;
Mapelli, D ;
Angeli, P ;
Iemmolo, R ;
Muraca, M ;
Musto, C ;
Gerunda, G ;
Rizzo, C ;
Merkel, C ;
Gatta, A .
JOURNAL OF HEPATOLOGY, 2001, 35 (01) :37-45
[4]
Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests [J].
Amodio, P ;
Del Piccolo, F ;
Marchetti, P ;
Angeli, P ;
Iemmolo, R ;
Caregaro, L ;
Merkel, C ;
Gerunda, G ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1662-1667
[5]
Amodio P, 2013, CLIN HEPATIC ENCEPHA, P63
[6]
Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat [J].
Amodio, Piero ;
Ampuero, Javier .
HEPATOLOGY, 2018, 67 (02) :476-478
[7]
Amodio P, 2015, CIRRHOSIS: A PRACTICAL GUIDE TO MANAGEMENT, P105
[8]
Smart Applications for Assessing Minimal Hepatic Encephalopathy: Novelty from the App Revolution [J].
Amodio, Piero ;
Cordoba, Juan .
HEPATOLOGY, 2013, 58 (03) :844-846
[9]
The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus [J].
Amodio, Piero ;
Bemeur, Chantal ;
Butterworth, Roger ;
Cordoba, Juan ;
Kato, Akinobu ;
Montagnese, Sara ;
Uribe, Misael ;
Vilstrup, Hendrik ;
Morgan, Marsha Y. .
HEPATOLOGY, 2013, 58 (01) :325-336
[10]
Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy [J].
Amodio, Piero ;
Ridola, Lorenzo ;
Schiff, Sami ;
Montagnese, Sara ;
Pasquale, Chiara ;
Nardelli, Silvia ;
Pentassuglio, Ilaria ;
Trezza, Maria ;
Marzano, Chiara ;
Flaiban, Cristiana ;
Angeli, Paolo ;
Cona, Giorgia ;
Bisiacchi, Patrizia ;
Gatta, Angelo ;
Riggio, Oliviero .
GASTROENTEROLOGY, 2010, 139 (02) :510-518